Table 2

DEHP metabolite concentrations of the study population

Percentile
Metabolitenn>LOD (%)GM (GSD)10th25th50th75th90th
Maternal blood
 MEHHP (ng/mL)105105 (100)0.31 (0.05)0.270.290.310.330.39
 MEOHP (ng/mL)1051 (1.0)<LOD<LOD<LOD<LOD<LOD
Maternal urine
 MEHHP (ng/mL)116116 (100)18.23 (28.82)5.0310.3917.7437.9760.42
 MEOHP (ng/mL)116116 (100)15.88 (27.58)4.939.3314.7029.5552.41
Cord blood
 MEHHP (ng/mL)101101 (100)0.33 (0.05)0.280.300.320.350.39
 MEOHP (ng/mL)1012 (2.0)<LOD<LOD<LOD<LOD<LOD
Placenta
 MEHHP (ng/g)115115 (100)0.10 (0.02)0.080.080.090.110.14
 MEOHP (ng/g)1151 (0.9)<LOD<LOD<LOD<LOD<LOD
Newborns’ urine
 MEHHP (ng/mL)7373 (100)5.83 (10.79)1.333.215.7911.8719.08
 MEOHP (ng/mL)7373 (100)3.02 (6.15)0.641.513.276.5010.00
  • DEHP, diethylhexyl phthalate; GM, geometric mean; GSD, geometric SD; MEHPP, mono-(2-ethyl-5-hydroxyhexyl) phthalate; MEOHP, mono-(2-ethyl-5-oxohexyl) phthalate.